Robert A. Fenstermaker

132 papers receiving 3.7k citations

Robert A. Fenstermaker's Hit Papers

Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma 2022 · 113 citations
1130+1+2Years since publication255075100

Peers

Robert A. Fenstermaker
Comparison fields: 5 of 114
  • Genetics 545
  • Immunology 721
  • Radiology, Nuclear Medicine and Imaging 635
  • Oncology 643
  • Neurology 282
Replace B A Kamen with:
B A Kamen United States
Shin Young Jeong South Korea
Werner Rosenau United States
Shin Jung South Korea
Walid S. Kamoun United States
Shin‐Ichi Miyatake Japan
Rolf M. Mesters Germany
Andreas Wicki Switzerland
Aarif Y. Khakoo United States
Erlinda M. Gordon United States
Robert A. Fenstermaker relative to B A Kamen United States B A Kamen's profile →
Citations per field
00.5×5.5×
B A Kamen · 1×
Citations per year

Countries citing papers authored by Robert A. Fenstermaker

Since Specialization
Citations

This map shows the geographic impact of Robert A. Fenstermaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Fenstermaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Fenstermaker more than expected).

Fields of papers citing papers by Robert A. Fenstermaker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Fenstermaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Fenstermaker. The network helps show where Robert A. Fenstermaker may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert A. Fenstermaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert A. Fenstermaker Line = papers co-authored together Robert A. Fenstermaker links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 136 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2012174
2 2003169
3 2006144
4 2016143
5 1989126
6 1996123
7
Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma
Hit paper breakdown →
2022113
8 2007107
9 2000102
10 200897
11 200692
12
Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas.
200286
13 201479
14 199476
15 198975
16 200574
17
Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
200266
18 200461
19 200157
20 200554

About Robert A. Fenstermaker

Robert A. Fenstermaker is a scholar working on Molecular Biology, Neurology, Genetics, Immunology and Oncology, having authored 136 papers that have together received 3.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (23 papers), Immunotherapy and Immune Responses (19 papers), RNA Interference and Gene Delivery (15 papers), Meningioma and schwannoma management (11 papers), Boron Compounds in Chemistry (10 papers), Neuroblastoma Research and Treatments (9 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Brain Metastases and Treatment (9 papers). The work is most often cited by research in Genetics (545 citations), Immunology (721 citations), Radiology, Nuclear Medicine and Imaging (635 citations), Oncology (643 citations) and Neurology (282 citations). Robert A. Fenstermaker has collaborated with scholars based in United States, Canada and Poland. Frequent co-authors include Michael J. Ciesielski, Rolf F. Barth, Weilian Yang, Werner Tjarks, Gong Wu, Robert J. Plunkett, Tara A. Barone, John H. Nilson, Jingxin Qiu and Debora L. Hamernik. Their work appears in journals such as Journal of Neuro-Oncology, Journal of Clinical Oncology, Cancer Immunology Immunotherapy, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact